相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Hans-Willi Mittrucker et al.
JOURNAL OF IMMUNOLOGY (2017)
The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma
J. K. Parrish et al.
ONCOGENE (2015)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
Gene Silencing Triggers Polycomb Repressive Complex 2 Recruitment to CpG Islands Genome Wide
Eva Madi Riising et al.
MOLECULAR CELL (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
Tsuyoshi Osawa et al.
CANCER RESEARCH (2013)
Control of Histone H3 Lysine 9 (H3K9) Methylation State via Cooperative Two-step Demethylation by Jumonji Domain Containing 1A (JMJD1A) Homodimer
Satoshi Goda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mcl-1 is essential for the survival of plasma cells
Victor Peperzak et al.
NATURE IMMUNOLOGY (2013)
Epigenetic Regulation of Mouse Sex Determination by the Histone Demethylase Jmjd1a
Shunsuke Kuroki et al.
SCIENCE (2013)
Targeting the BRAF V600E Mutation in Multiple Myeloma
Mindaugas Andrulis et al.
CANCER DISCOVERY (2013)
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma
Naoya Mimura et al.
BLOOD (2012)
Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia
Takaomi Sanda et al.
CANCER CELL (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors
Carolina Vicente-Duenas et al.
EMBO JOURNAL (2012)
The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene
Hyun-Soo Cho et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Cutting Edge: Kruppel-like Factor 2 Is Required for Phenotypic Maintenance but Not Development of B1 B Cells
Geoffrey T. Hart et al.
JOURNAL OF IMMUNOLOGY (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
Eva Martinez-Garcia et al.
BLOOD (2011)
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
Paola Neri et al.
BLOOD (2011)
A Novel Transgenic Mouse Model of the Human Multiple Myeloma Chromosomal Translocation t(14;16)(q32;q23)
Naoki Morito et al.
CANCER RESEARCH (2011)
NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
Alex J. Kuo et al.
MOLECULAR CELL (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression
Geoffrey T. Hart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
B cell homeostasis and plasma cell homing controlled by Kruppel-like factor 2
Rebecca Winkelmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor Cells
Mamoru Uemura et al.
CLINICAL CANCER RESEARCH (2010)
Follicular B Cell Trafficking within the Spleen Actively Restricts Humoral Immune Responses
Kristen L. Hoek et al.
IMMUNITY (2010)
Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 alpha Enhances Hypoxic Gene Expression and Tumor Growth
Adam J. Krieg et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Douglas W. McMillin et al.
NATURE MEDICINE (2010)
Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases
John R. Horton et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice
Takeshi Inagaki et al.
GENES TO CELLS (2009)
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance
Keisuke Tateishi et al.
NATURE (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
arrayQualityMetrics—a bioconductor package for quality assessment of microarray data
Audrey Kauffmann et al.
BIOINFORMATICS (2008)
The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF
Sophie Beyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hepatocyte nuclear factor 4α contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9
Hiroto Ohguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor
Wolfgang Schuh et al.
MOLECULAR IMMUNOLOGY (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis
Yuki Okada et al.
NATURE (2007)
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells
Yuin-Han Loh et al.
GENES & DEVELOPMENT (2007)
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Teru Hideshima et al.
NATURE REVIEWS CANCER (2007)
Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia:: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals
N. C. Gutierrez et al.
LEUKEMIA (2007)
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Fenghuang Zhan et al.
BLOOD (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation
Roger Sciammas et al.
IMMUNITY (2006)
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Ulf Klein et al.
NATURE IMMUNOLOGY (2006)
JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor
Kenichi Yamane et al.
CELL (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Core transcriptional regulatory circuitry in human embryonic stem cells
LA Boyer et al.
CELL (2005)
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
EM Hurt et al.
CANCER CELL (2004)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Sp1-and Kruppel-like transcription factors
J Kaczynski et al.
GENOME BIOLOGY (2003)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays
T Yuen et al.
NUCLEIC ACIDS RESEARCH (2002)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection
C Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
